9 Meters Biopharma (NMTR) News Today → The most important AI company you've never heard of (From Manward Press) (Ad) Free NMTR Stock Alerts Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesSEC FilingsSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesSEC FilingsSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative December 14, 2023 | bbc.comEnergy firms likely to miss smart meter deadline, warns Which?November 8, 2023 | bizjournals.comDeal reached to sell some assets of bankrupt Raleigh firmNovember 7, 2023 | finance.yahoo.com9 Meters Biopharma, Inc. (NMTRQ)October 17, 2023 | investing.com9 Meters Biopharma Inc (NMTRQ)August 16, 2023 | fool.com9 Meters Biopharma (OTC: NMTR.Q)July 18, 2023 | bizjournals.comRaleigh firm joins worrying trend of bankruptcies for drugmakersJuly 18, 2023 | reuters.comDrug developer 9 Meters Biopharma files for bankruptcy protectionJuly 18, 2023 | finance.yahoo.comWhy Are 9 Meters Biopharma Shares Nosediving Today?May 30, 2023 | bizjournals.comTemperato resigns as CEO of Raleigh drugmakerMay 30, 2023 | finance.yahoo.com9 Meters Biopharma Announces Management Change and Provides Clinical Update on Vurolenatide in Patients with Short Bowel SyndromeMay 28, 2023 | fool.com9 Meters Biopharma (NASDAQ: NMTR)May 25, 2023 | uk.finance.yahoo.comNMTR - 9 Meters Biopharma, Inc.May 19, 2023 | msn.comCitigroup Maintains 9 Meters Biopharma (NMTR) Neutral RecommendationMay 15, 2023 | finance.yahoo.com9 Meters Biopharma Provides Business Update and Reports Financial Results for First Quarter 2023April 5, 2023 | finance.yahoo.com9 Meters Biopharma Announces Successful Pre-IND Meeting with FDA Regarding Its GIP Antagonist NM-136 for ObesityMarch 30, 2023 | bizjournals.comWhy this Raleigh pharma just cut half its workforceMarch 28, 2023 | finance.yahoo.com9 Meters Biopharma Provides Business Update and Reports Financial Results for Fourth Quarter and Full Year 2022March 25, 2023 | seekingalpha.comNMTR 9 Meters Biopharma, Inc.March 22, 2023 | benzinga.com9 Meters Biopharma Stock (NASDAQ:NMTR), Guidance and ForecastMarch 16, 2023 | bizjournals.comRaleigh pharma raises $5M as phase 3 study beginsMarch 15, 2023 | finance.yahoo.com9 Meters Biopharma Announces Closing of $5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesMarch 14, 2023 | finance.yahoo.com9 Meters Biopharma Announces $5 Million Registered Direct Offering Priced at-the-Market Under Nasdaq RulesMarch 7, 2023 | finance.yahoo.com9 Meters Biopharma to Present at the Oppenheimer 33rd Annual Healthcare ConferenceFebruary 23, 2023 | theguardian.comSuppliers told to remove prepayment meters that were wrongly force-fittedJanuary 31, 2023 | finance.yahoo.com9 Meters Biopharma to Present at the 2023 BIO CEO & Investor ConferenceJanuary 17, 2023 | theguardian.comLabour calls for halt to ‘shameful’ forced installation of prepayment metersJanuary 15, 2023 | theguardian.comMPs warn over forced prepayment meters as cold weather returnsJanuary 14, 2023 | news.yahoo.comEnergy bills: 'I was forced onto a prepayment meter'January 14, 2023 | thetimes.co.ukMillions of families forced to have prepayment gas and electric metersNovember 29, 2022 | finance.yahoo.com9 Meters Biopharma Announces Phase 3 Study of Vurolenatide in Short Bowel SyndromeNovember 14, 2022 | finance.yahoo.com9 Meters Biopharma Announces Continued Immuno-Oncology Collaboration with Gustave RoussyNovember 8, 2022 | finance.yahoo.com9 Meters Biopharma Provides Business Update and Reports Financial Results for Third Quarter 2022October 24, 2022 | finance.yahoo.com9 Meters Biopharma Presents Preclinical Data on Glucose-Dependent Insulinotropic Polypeptide (GIP) Monoclonal Antibodies for Obesity at the American College of Gastroenterology 2022 Annual Scientific MeetingOctober 18, 2022 | bizjournals.com9 Meters Biopharma triggers reverse stock split to maintain Nasdaq listingOctober 18, 2022 | finance.yahoo.com9 Meters Biopharma to Present at the American College of Gastroenterology (ACG) 2022 Annual Scientific MeetingOctober 17, 2022 | finance.yahoo.com9 Meters Biopharma Announces 1-for-20 Reverse Stock SplitSeptember 27, 2022 | seekingalpha.com9 Meters Biopharma gains after mid-stage data for short bowel syndrome drugSeptember 26, 2022 | finance.yahoo.com9 Meters Biopharma Announces Positive Final Results from Phase 2 VIBRANT Study and Successful End-of-Phase 2 Meeting with FDA for Vurolenatide in Short Bowel SyndromeSeptember 6, 2022 | finance.yahoo.com9 Meters Biopharma to Present at the H.C. Wainwright 24th Annual Global Investment ConferenceSeptember 1, 2022 | finance.yahoo.com9 Meters Biopharma to Participate at the 44th European Society for Clinical Nutrition and Metabolism (ESPEN) CongressAugust 31, 2022 | finance.yahoo.com9 Meters Biopharma to Participate in the Citi 17th Annual BioPharma ConferenceAugust 13, 2022 | uk.finance.yahoo.com9 Meters Biopharma, Inc. (NMTR)July 6, 2022 | finance.yahoo.com9 Meters Biopharma to Participate in the William Blair Biotech Focus Conference 2022July 5, 2022 | bizjournals.comRaleigh drugmaker shifts focus after trial setbackJune 30, 2022 | seekingalpha.com9 Meters stock falls despite drug showing promise in short bowel syndrome trialJune 30, 2022 | seekingalpha.com9 Meters gets $70M debt facility for phase 3 development of short bowel syndrome drugJune 30, 2022 | finance.yahoo.com9 Meters Biopharma Announces Positive Preliminary Results from Phase 2 Study of Vurolenatide in Short Bowel SyndromeJune 30, 2022 | finance.yahoo.com9 Meters Biopharma Announces Debt Facility to Support Phase 3 Study of Vurolenatide for Short Bowel SyndromeJune 22, 2022 | finance.yahoo.comRaleigh pharma sees stock tumble after stopping trial. Now what?June 21, 2022 | seekingalpha.com9 Meters stock slumps 54% as phase 3 Celiac disease trial of larazotide gets axed Get 9 Meters Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for NMTR and its competitors with MarketBeat's FREE daily newsletter. Email Address A ‘DeFi Summer’ Projected! (Ad)Top analysts are predicting DeFi coins to see massive gains in the coming months… During this dubbed ‘DeFi Summer…’ A coin that has been called the “DeFi pioneer” is poised to shoot up 3-7x! Just click here to learn how you can access this coin right now. NMTR Media Mentions By Week NMTR Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NMTR News Sentiment▼0.000.55▲Average Medical News Sentiment NMTR News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NMTR Articles This Week▼00▲NMTR Articles Average Week Get 9 Meters Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for NMTR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: EIGR News SBFM News SINT News VRAX News BBLG News EVLO News SPRC News TCBP News EVFM News ACOR News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NMTR) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportAmazon's betting big on this unknown AI companyManward PressThis Wall Street stock prediction just went viralChaikin AnalyticsThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTop 5 AI Stocks to Buy for 2024Market Moving TrendsTop 5 Tech Stocks to Buy for 2024Daily Market AlertsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 9 Meters Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
